- Home
- IXHL vs CNF Comparison
IXHL vs CNF Comparison
Compare IXHL & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | IXHL | CNF |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | Australia | China |
| Employees | 12 | 326 |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 32.7M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IXHL | CNF |
|---|---|---|
| Price | $2.77 | $1.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.6K | 7.4K |
| Earning Date | 11-13-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $1.37 |
| 52 Week High | $6.39 | $6.49 |
Technical Indicators
Market Signals| Indicator | IXHL | CNF |
|---|---|---|
| Relative Strength Index (RSI) | 30.81 | 48.63 |
| Support Level | $2.79 | $1.74 |
| Resistance Level | $3.89 | $2.19 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 6.65 | 67.44 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.